Sawai Group Holdings Co., Ltd.

4887

JP3323040000

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 14:30:00 23/01/2026 HKT			5-day change	1st Jan Change
2,425.00 ^JPY	+0.37%		+1.63%	+2.80%

12-11	Jefferies Adjusts Sawai Group Holdings' Price Target to 2,100 Yen From 2,000 Yen, Keeps at Hold	MT
12-04	Morgan Stanley Starts Sawai Group at Overweight with 2,600 Yen Price Target	MT

Sawai Group Settles Patent Dispute with Asahi Kasei for 4 Billion Yen

Published on 10/21/2025 at 10:31 am HKT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Sawai Group Holdings Co., Ltd.

12-11	Jefferies Adjusts Sawai Group Holdings' Price Target to 2,100 Yen From 2,000 Yen, Keeps at Hold	MT
12-04	Morgan Stanley Starts Sawai Group at Overweight with 2,600 Yen Price Target	MT
11-14	Sawai Group Holdings Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 1, 2025	CI
11-10	Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2025 and the Full Year Ending March 31, 2026	CI
21/10/25	Japanese Shares Rise as Takaichi Becomes Japan's First Female Prime Minister	MT
21/10/25	Sawai Group Settles Patent Dispute with Asahi Kasei for 4 Billion Yen	MT
21/10/25	Sawai Group Holdings Co: Sawai Pharmaceutical Co has reached settlement with Asahi Kasei Pharma regarding patent infringement lawsuit concerning teriparatide for subcutaneous injection 56.5ug	RE
12/08/25	Sawai Group Holdings Profit Plunges 68% in Fiscal Q1	MT
12/08/25	Sawai Group Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
17/07/25	Jefferies Adjusts Sawai Group Holdings' Price Target to 2,000 Yen From 1,900 Yen, Keeps at Hold	MT
30/06/25	Sawai Group Holdings Co., Ltd. completed the acquisition of FrontAct Co., Ltd. from Sumitomo Pharma Co., Ltd..	CI
10/06/25	Sawai Group Holdings Files Final Appeal in Patent Lawsuit	MT
15/05/25	Jefferies Adjusts Sawai Group Holdings' Price Target to 1,900 Yen From 2,100 Yen, Keeps at Hold	MT
14/05/25	Sawai Group Holdings Co., Ltd. Announces Board and Committee Changes on June 25, 2025	CI
14/05/25	Sawai Group Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
14/05/25	Sawai Group Holdings Co., Ltd. Announces Cash Dividend for the Fiscal Year Ended March 31, 2025, Payable on June 26, 2025	CI
14/05/25	Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter Ending September 30, 2025 and Fiscal Year Ending March 31, 2026	CI
14/05/25	Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2025 and Fiscal Year Ending March 31, 2026	CI
28/04/25	Sawai to Retire 16 Million Shares	MT
25/04/25	Sawai Group Holdings Co Ltd - To Retire Treasury Shares Worth 12.2% Of Outstanding Stock On April 30	RE
28/03/25	Sawai Group Holdings Co., Ltd. agreed to acquire FrontAct Co., Ltd. from Sumitomo Pharma Co., Ltd..	CI
27/02/25	Tranche Update on Sawai Group Holdings Co., Ltd.'s Equity Buyback Plan announced on June 25, 2024.	CI
26/02/25	Sawai Group Holdings Co., Ltd.'s Equity Buyback announced on June 25, 2024, has closed with 16,016,600 shares, representing 13.03% for ¥32,999.83 million.	CI
14/02/25	Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2025	CI
06/02/25	Sawai Group Repurchases 1.4 Million Shares	MT

Chart Sawai Group Holdings Co., Ltd.

Duration

Period

4887: Dynamic Chart

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

Employees

3,310

Sector

Pharmaceuticals

Calendar

02-13 - Q3 2025 Earnings Release

More about the company